Lomofungin and dilomofungin: Inhibitors of MBNL1-CUG RNA binding with distinct cellular effects

Nucleic Acids Research

Volumn 42, Issue 10, 2014, Pages 6591-6602

  Hoskins, Jason W ^a   Ofori, Leslie O ^b   Chen, Catherine Z ^c   Kumar, Amit ^d   Sobczak, Krzysztof ^a   Nakamori, Masayuki ^a   Southall, Noel ^c   Patnaik, Samarjit ^c   Marugan, Juan J ^c   Zheng, Wei ^c   Austin, Christopher P ^c   Disney, Matthew D ^d   Miller, Benjamin L ^b   Thornton, Charles A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS AFFECTING PROTEIN METABOLISM; CELL PROTEIN; DILOMOFUNGIN; DIMETHYL SULFOXIDE; LOMOFUNGIN; MONOMER; PROTEIN INHIBITOR; PROTEIN MBNL1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CUG REPEAT; DIMERIZATION; DNA STRUCTURE; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG TARGETING; HIGH THROUGHPUT SCREENING; IC 50; INHIBITION KINETICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RNA METABOLISM; RNA SPLICING;

3' UNTRANSLATED REGIONS; ALTERNATIVE SPLICING; DIMERIZATION; HUMANS; PHENAZINES; REPETITIVE SEQUENCES, NUCLEIC ACID; RNA; RNA STABILITY; RNA-BINDING PROTEINS;

EID: 84903199965     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku275     Document Type: Article

References (71)

1. Todd, P.K. and Paulson, H.L. (2010) RNA-mediated neurodegeneration in repeat expansion disorders. Ann. Neurol., 67, 291-300.
2. Kobayashi, H., Abe, K., Matsuura, T., Ikeda, Y., Hitomi, T., Akechi, Y., Habu, T., Liu, W., Okuda, H. and Koizumi, A. (2011) Expansion of intronic GGCCTG hexanucleotide repeat in NOP56 causes SCA36, a type of spinocerebellar ataxia accompanied by motor neuron involvement. Am. J. Hum. Genet., 89, 121-130.
3. Li, Y. and Jin, P. (2012) RNA-mediated neurodegeneration in fragile X-associated tremor/ataxia syndrome. Brain Res., 1462, 112-117.
4. Liquori, C.L., Ricker, K., Moseley, M.L., Jacobsen, J.F., Kress, W., Naylor, S.L., Day, J.W. and Ranum, L.P. (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science, 293, 864-867.
5. Sato, N., Amino, T., Kobayashi, K., Asakawa, S., Ishiguro, T., Tsunemi, T., Takahashi, M., Matsuura, T., Flanigan, K.M., Iwasaki, S. et al. (2009) Spinocerebellar ataxia type 31 is associated with "inserted" penta-nucleotide repeats containing (TGGAA)n. Am. J. Hum. Genet., 85, 544-557.
6. White, M.C., Gao, R., Xu, W., Mandal, S.M., Lim, J.G., Hazra, T.K., Wakamiya, M., Edwards, S.F., Raskin, S., Teive, H.A. et al. (2010) Inactivation of hnRNP K by expanded intronic AUUCU repeat induces apoptosis via translocation of PKCdelta to mitochondria in spinocerebellar ataxia 10. PLoS Genet., 6, e1000984.
7. DeJesus-Hernandez, M., Mackenzie, I.R., Boeve, B.F., Boxer, A.L., Baker, M., Rutherford, N.J., Nicholson, A.M., Finch, N.A., Flynn, H., Adamson, J. et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72, 245-256.
8. Renton, A.E., Majounie, E., Waite, A., Simon-Sanchez, J., Rollinson, S., Gibbs, J.R., Schymick, J.C., Laaksovirta, H., van Swieten, J.C., Myllykangas, L. et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72, 257-268.
9. Wieben, E.D., Aleff, R.A., Tosakulwong, N., Butz, M.L., Highsmith, W.E., Edwards, A.O. and Baratz, K.H. (2012) A common trinucleotide repeat expansion within the transcription factor 4 (TCF4, E2-2) gene predicts Fuchs corneal dystrophy. PLoS One, 7, e49083.
10. Krzyzosiak, W.J., Sobczak, K., Wojciechowska, M., Fiszer, A., Mykowska, A. and Kozlowski, P. (2012) Triplet repeat RNA structure and its role as pathogenic agent and therapeutic target. Nucleic Acids Res., 40, 11-26.
11. Brook, J.D., McCurrach, M.E., Harley, H.G., Buckler, A.J., Church, D., Aburatani, H., Hunter, K., Stanton, V.P., Thirion, J.P., Hudson, T. et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell, 68, 799-808.
12. Lopez Castel, A., Nakamori, M., Tome, S., Chitayat, D., Gourdon, G., Thornton, C.A. and Pearson, C.E. (2011) Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues. Hum. Mol. Genet., 20, 1-15.
13. Taneja, K.L., McCurrach, M., Schalling, M., Housman, D. and Singer, R.H. (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol., 128, 995-1002.
14. Davis, B.M., McCurrach, M.E., Taneja, K.L., Singer, R.H. and Housman, D.E. (1997) Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. U. S. A., 94, 7388-7393.
15. Miller, J.W., Urbinati, C.R., Teng-Umnuay, P., Stenberg, M.G., Byrne, B.J., Thornton, C.A. and Swanson, M.S. (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J., 19, 4439-4448.
16. Lin, X., Miller, J.W., Mankodi, A., Kanadia, R.N., Yuan, Y., Moxley, R.T., Swanson, M.S. and Thornton, C.A. (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet., 15, 2087-2097.
17. Ho, T.H., Charlet, B.N., Poulos, M.G., Singh, G., Swanson, M.S. and Cooper, T.A. (2004) Muscleblind proteins regulate alternative splicing. EMBO J., 23, 3103-3112.
18. Nakamori, M., Sobczak, K., Puwanant, A., Welle, S., Eichinger, K., Pandya, S., Dekdebrun, J., Heatwole, C.R., McDermott, M.P., Chen, T. et al. (2013) Splicing biomarkers of disease severity in myotonic dystrophy. Ann. Neurol., 74, 862-872.
19. Wang, E.T., Cody, N.A., Jog, S., Biancolella, M., Wang, T.T., Treacy, D.J., Luo, S., Schroth, G.P., Housman, D.E., Reddy, S. et al. (2012) Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell, 150, 710-724.
20. Savkur, R.S., Philips, A.V. and Cooper, T.A. (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet., 29, 40-47.
21. Wheeler, T.M., Lueck, J.D., Swanson, M.S., Dirksen, R.T. and Thornton, C.A. (2007) Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Invest., 117, 3952-3957.
22. Arambula, J.F., Ramisetty, S.R., Baranger, A.M. and Zimmerman, S.C. (2009) A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding. Proc. Natl. Acad. Sci. U. S. A., 106, 16068-16073.
23. Childs-Disney, J.L., Hoskins, J., Rzuczek, S.G., Thornton, C.A. and Disney, M.D. (2012) Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive. ACS Chem. Biol., 7, 856-862.
24. Gareiss, P.C., Sobczak, K., McNaughton, B.R., Palde, P.B., Thornton, C.A. and Miller, B.L. (2008) Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1). J. Am. Chem. Soc., 130, 16254-16261.
25. Mulders, S.A., van den Broek, W.J., Wheeler, T.M., Croes, H.J., van Kuik-Romeijn, P., de Kimpe, S.J., Furling, D., Platenburg, G.J., Gourdon, G., Thornton, C.A. et al. (2009) Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc. Natl. Acad. Sci. U. S. A., 106, 13915-13920.
26. Ofori, L.O., Hoskins, J., Nakamori, M., Thornton, C.A. and Miller, B.L. (2012) From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy. Nucleic Acids Res., 40, 6380-6390.
27. Parkesh, R., Childs-Disney, J.L., Nakamori, M., Kumar, A., Wang, E., Wang, T., Hoskins, J., Tran, T., Housman, D., Thornton, C.A. et al. (2012) Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching. J. Am. Chem. Soc., 134, 4731-4742.
28. Pushechnikov, A., Lee, M.M., Childs-Disney, J.L., Sobczak, K., French, J.M., Thornton, C.A. and Disney, M.D. (2009) Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3. J. Am. Chem. Soc., 131, 9767-9779.
29. Warf, M.B., Nakamori, M., Matthys, C.M., Thornton, C.A. and Berglund, J.A. (2009) Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc. Natl. Acad. Sci. U. S. A., 106, 18551-18556.
30. Wheeler, T.M., Sobczak, K., Lueck, J.D., Osborne, R.J., Lin, X., Dirksen, R.T. and Thornton, C.A. (2009) Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science, 325, 336-339.
31. Wheeler, T.M., Leger, A.J., Pandey, S.K., MacLeod, A.R., Nakamori, M., Cheng, S.H., Wentworth, B.M., Bennett, C.F. and Thornton, C.A. (2012) Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature, 488, 111-115.
32. Disney, M.D., Labuda, L.P., Paul, D.J., Poplawski, S.G., Pushechnikov, A., Tran, T., Velagapudi, S.P., Wu, M. and Childs-Disney, J.L. (2008) Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners. J. Am. Chem. Soc., 130, 11185-11194.
33. Disney, M.D., Lee, M.M., Pushechnikov, A. and Childs-Disney, J.L. (2010) The role of flexibility in the rational design of modularly assembled ligands targeting the RNAs that cause the myotonic dystrophies. Chembiochem, 11, 375-382.
34. Jahromi, A.H., Fu, Y., Miller, K.A., Nguyen, L., Luu, L.M., Baranger, A.M. and Zimmerman, S.C. (2013) Developing Bivalent Ligands to Target CUG Triplet Repeats, the Causative Agent of Myotonic Dystrophy Type 1. J. Med. Chem., 56, 9471-9481.
35. Bergy, M.E. (1969) Lomofungin, a new broad spectrum antibiotic. Isolation and characterization. J. Antibiot. (Tokyo), 22, 126-128.
36. Johnson, L.E. and Dietz, A. (1969) Lomofungin, a new antibiotic produced by Streptomyces lomondensis sp. n. Appl. Microbiol., 17, 755-759.
37. Chen, C.Z., Sobczak, K., Hoskins, J., Southall, N., Marugan, J.J., Zheng, W., Thornton, C.A. and Austin, C.P. (2012) Two high-throughput screening assays for aberrant RNA-protein interactions in myotonic dystrophy type 1. Anal. Bioanal. Chem., 402, 1889-1898.
38. Feng, B.Y., Simeonov, A., Jadhav, A., Babaoglu, K., Inglese, J., Shoichet, B.K. and Austin, C.P. (2007) A high-throughput screen for aggregation-based inhibition in a large compound library. J. Med. Chem., 50, 2385-2390.
39. Peyret, N., Seneviratne, P.A., Allawi, H.T. and SantaLucia, J. Jr (1999) Nearest-neighbor thermodynamics and NMR of DNA sequences with internal A.A, C.C, G.G, and T.T mismatches. Biochemistry, 38, 3468-3477.
40. SantaLucia, J. Jr (1998) A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc. Natl. Acad. Sci. U. S. A., 95, 1460-1465.
41. SantaLucia, J. Jr, Kierzek, R. and Turner, D.H. (1992) Context dependence of hydrogen bond free energy revealed by substitutions in an RNA hairpin. Science, 256, 217-219.
42. Chaires, J.B. (2003) A competition dialysis assay for the study of structure-selective ligand binding to nucleic acids. Curr. Protoc. Nucleic Acid Chem., 11, 8.3.1-8.3.8.
43. SantaLucia, J. Jr and Hicks, D. (2004) The thermodynamics of DNA structural motifs. Annu. Rev. Biophys. Biomol. Struct., 33, 415-440.
44. Nakamori, M., Pearson, C.E. and Thornton, C.A. (2011) Bidirectional transcription stimulates expansion and contraction of expanded (CTG)*(CAG) repeats. Hum. Mol. Genet., 20, 580-588.
45. Inglese, J., Auld, D.S., Jadhav, A., Johnson, R.L., Simeonov, A., Yasgar, A., Zheng, W. and Austin, C.P. (2006) Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc. Natl. Acad. Sci. U. S. A., 103, 11473-11478.
46. Cannon, M., Davies, J.E. and Jimenez, A. (1973) Inhibition by lomofungin of nucleic acid and protein synthesis in Saccharomyces cerevisiae. FEBS Lett., 32, 277-280.
47. Henras, A.K., Soudet, J., Gerus, M., Lebaron, S., Caizergues-Ferrer, M., Mougin, A. and Henry, Y. (2008) The post-transcriptional steps of eukaryotic ribosome biogenesis. Cell. Mol. Life Sci., 65, 2334-2359.
48. Hino, S., Kondo, S., Sekiya, H., Saito, A., Kanemoto, S., Murakami, T., Chihara, K., Aoki, Y., Nakamori, M., Takahashi, M.P. et al. (2007) Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1. Hum. Mol. Genet., 16, 2834-2843.
49. Tor, Y. (2003) Targeting RNA with small molecules. Chembiochem, 4, 998-1007.
50. Thomas, J.R. and Hergenrother, P.J. (2008) Targeting RNA with small molecules. Chem. Rev., 108, 1171-1224.
51. Wilson, D.N. (2013) Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat. Rev. Microbiol., 12, 35-48.
52. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M. and Thornton, C.A. (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science, 289, 1769-1773.
53. Napierala, M. and Krzyzosiak, W.J. (1997) CUG repeats present in myotonin kinase RNA form metastable "slippery" hairpins. J. Biol. Chem., 272, 31079-31085.
54. Tian, B., White, R.J., Xia, T., Welle, S., Turner, D.H., Mathews, M.B. and Thornton, C.A. (2000) Expanded CUG repeat RNAs form hairpins that activate the double-stranded RNA-dependent protein kinase PKR. RNA, 6, 79-87.
55. Mooers, B.H., Logue, J.S. and Berglund, J.A. (2005) The structural basis of myotonic dystrophy from the crystal structure of CUG repeats. Proc. Natl. Acad. Sci. U. S. A., 102, 16626-16631.
56. Human BodyMap 2.0 data from Illumina (2011). http://www.ensembl.info/ blog/2011/05/24/human-bodymap-2-0-data-from-illumina/10.1093/nar/gku275.html.
57. Haghighat Jahromi, A., Honda, M., Zimmerman, S.C. and Spies, M. (2013) Single-molecule study of the CUG repeat-MBNL1 interaction and its inhibition by small molecules. Nucleic Acids Res., 41, 6687-6697.
58. Jiang, H., Mankodi, A., Swanson, M.S., Moxley, R.T. and Thornton, C.A. (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum. Mol. Genet., 13, 3079-3088.
59. Mammen, M., Choi, S.K. and Whitesides, G.M. (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew. Chem. Int. Ed., 37, 2754-2794.
60. Kitov, P.I. and Bundle, D.R. (2003) On the nature of the multivalency effect: a thermodynamic model. J. Am. Chem. Soc., 125, 16271-16284.
61. Lee, K.Y., Li, M., Manchanda, M., Batra, R., Charizanis, K., Mohan, A., Warren, S.A., Chamberlain, C.M., Finn, D., Hong, H. et al. (2013) Compound loss of muscleblind-like function in myotonic dystrophy. EMBO Mol. Med., 5, 1887-1900.
62. Leger, A.J., Mosquea, L.M., Clayton, N.P., Wu, I.H., Weeden, T., Nelson, C.A., Phillips, L., Roberts, E., Piepenhagen, P.A., Cheng, S.H. et al. (2013) Systemic delivery of a peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy. Nucleic Acid Ther., 23, 109-117.
63. O'Leary, D.A., Vargas, L., Sharif, O., Garcia, M.E., Sigal, Y.J., Chow, S.K., Schmedt, C., Caldwell, J.S., Brinker, A. and Engels, I.H. (2010) HTS-compatible patient-derived cell-based assay to identify small molecule modulators of aberrant splicing in myotonic dystrophy type 1. Curr. Chem. Genomics, 4, 9-18.
64. Ketley, A., Chen, C.Z., Li, X., Arya, S., Robinson, T.E., Granados-Riveron, J., Udosen, I., Morris, G.E., Holt, I., Furling, D. et al. (2013) High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines. Hum. Mol. Genet., 23, 1551-1562.
65. Chapman, R.L., Stanley, T.B., Hazen, R. and Garvey, E.P. (2002) Small molecule modulators of HIV Rev/Rev response element interaction identified by random screening. Antiviral Res., 54, 149-162.
66. Ellenbecker, M., Lanchy, J.M. and Lodmell, J.S. (2012) Identification of Rift Valley fever virus nucleocapsid protein-RNA binding inhibitors using a high-throughput screening assay. J. Biomol. Screen, 17, 1062-1070.
67. Childs-Disney, J.L., Stepniak-Konieczna, E., Tran, T., Yildirim, I., Park, H., Chen, C.Z., Hoskins, J., Southall, N., Marugan, J.J., Patnaik, S. et al. (2013) Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules. Nat. Commun., 4, 2044.
68. Pohjala, L. and Tammela, P. (2012) Aggregating behavior of phenolic compounds-a source of false bioassay results? Molecules, 17, 10774-10790.
69. Feng, B.Y. and Shoichet, B.K. (2006) A detergent-based assay for the detection of promiscuous inhibitors. Nat. Protoc., 1, 550-553.
70. Lee, M.M., Childs-Disney, J.L., Pushechnikov, A., French, J.M., Sobczak, K., Thornton, C.A. and Disney, M.D. (2009) Controlling the specificity of modularly assembled small molecules for RNA via ligand module spacing: targeting the RNAs that cause myotonic muscular dystrophy. J. Am. Chem. Soc., 131, 17464-17472.
71. Masuda, A., Andersen, H.S., Doktor, T.K., Okamoto, T., Ito, M., Andresen, B.S. and Ohno, K. (2012) CUGBP1 and MBNL1 preferentially bind to 3′ UTRs and facilitate mRNA decay. Sci. Rep., 2, 209.